Effects of erdosteine on smoking-induced lipid peroxidation in healthy smokers

Drugs in R and D

Volumn 6, Issue 2, 2005, Pages 83-89

  Basyigit, Ilknur ^a,b   Yildiz, Fusun ^a   Cekmen, Mustafa ^a   Duman, Can ^a   Bulut, Olcay ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; ERDOSTEINE; ERDOSTIN; LIPID; MALONALDEHYDE; NITRATE; NITRITE; PLACEBO; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; LUNG DISEASE; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; SPIROMETRY; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; NITRATES; NITRITES; SMOKING; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOGLYCOLATES; THIOPHENES;

EID: 16844372083     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200506020-00003     Document Type: Article

References (40)

1. Repine JE, Bast A, Lankhorst I, et al. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156 (2): 341-57
2. Macnee W, Rahman I. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med 2001; 7 (2): 55-62
3. Kharitonov SA, Robbins RA, Yates D, et al. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152 (2): 609-12
4. Maniscalco M, Di Mauro V, Farinaro, E, et al. Transient decrease of exhaled nitric oxide after acute exposure to passive smoke in healthy subjects. Arch Environ Health 2002; 57 (5): 437-40
5. Yates DH, Breen H, Thomas PS. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. Am J Respir Crit Care Med 2001; 164 (6): 1043-6
6. Schilling J, Holzer P, Guggenbach M, et al. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur J Respir Dis 1994; 7 (3): 467-71
7. Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998; 106 Suppl. 5: 1229-34
8. Moore K, Roberts II LJ. Measurement of lipid peroxidation. Free Radic Res 1998; 28 (6): 659-71
9. Halimi JM, Mimran A. Systemic and renal effects of nicotine in non-smokers: influence of vitamin C. J Hypertens 2000; 18 (11): 1665-9
10. Valkonen MM, Kuusi T. Vitamin C prevents acute atherogenic effects of passive smoking. Free Radic Biol Med 2000; 28 (3): 428-36
11. Dechant KL, Noble S. Erdosteine. Drugs 1996; 52 (6): 875-81
12. Granger DL, Taintor RR, Bookvar KS, et al. Measurement of nitrite and nitrate in biological samples using nitrate reductase and Greiss reaction. Methods Enzymol 1996; 268: 142-51
13. Balat A, Cekmen M, Yurekli M, et al. Adrenomedullin and nitrite levels in children with Bartter Syndrome. Int J Pediatr Nephrol 2000; 15: 266-70
14. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 12: 302-10
15. Lapenna D, Ciofani G, Pierdomenico SD, et al. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 2001; 31: 331-5
16. Wewers ME, Ahijevych KL, Dhatt RK, et al. Cotinine levels in Southeast Asian smokers. Nicotine Tob Res 2000; 2 (1): 85-91
17. Behera D, Uppal R, Majumdar S. Urinary levels of nicotine and cotinine in tobacco users. Indian J Med Res 2003; 118: 129-33
18. Wong GC, Berman BA, Hoang T, et al. Children's exposure to environmental tobacco smoke in the home: comparison of urine cotinine and parental reports. Arch Environ Health 2002; 57 (6): 584-90
19. Sakurai Y, Kanazawa I. Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions. Hum Psychopharmacol 2002; 17 (7): 369-73
20. Chambers DC, Tunnicliffe WS, Ayres JG. Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax 1998; 53: 677-9
21. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163 (7): 1693-772
22. Persson MG, Zetterstrom O, Agrenius V, et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343 (8890): 146-7
23. Tsuchiya M, Asada A, Kasahara E, et al. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002; 105: 1155-7
24. Dweik RA, Laskowski D, Abu-Soud HM, et al. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 1998; 101 (3): 660-6
25. Vassalle C, Lubrano V, L'Abbate A, et al. Determination of nitrite plus nitrate and malondialdehyde in human plasma: analytical performance and the effect of smoking and exercise. Clin Chem Lab Med 2002; 40 (8): 802-9
26. Node K, Kitakaze M, Yoshikawa H, et al. Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 1997; 79 (11): 1538-41
27. Ozbay, Dulger H. Lipid peroxidation and antioxidant enzymes in a Turkish population: relation to age, gender, exercise and smoking. Tohoku J Exp Med 2002; 197 (2): 119-24
28. Durak I, Bingol NK, Avci A, et al. Acute effects of cigarettes with different tar content on plasma oxidant/antioxidant status. Inhal Toxicol 2000; 12 (7): 641-7
29. Kim HS, Lee BM. Protective effects of antioxidant supplementation on plasma lipid peroxidation in smokers. J Toxicol Environ Health A 2001; 63 (8): 583-98
30. Lu Q, Bjorkhem I, Xiu RJ, et al. N-acetylcysteine improves microcirculatory flow during smoking: new effects of an old drug with possible benefits for smokers. Clin Cardiol 2001; 24 (7): 511-5
31. Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001; 95 (6): 448-56
32. Hayashi K, Hosoe H, Kaise T, et al. Protective effect of erdosteine against hypochlorous acid-induced acute lung injury and lipopolysaccharide-induced neutrophilic lung inflammation in mice. J Pharm Pharmacol 2000; 52 (11): 1411-6
33. Jang YY, Song JH, Shin YK, et al. Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide. Pharmacol Toxicol 2003; 92 (4): 173-9
34. Yildirim Z, Sogut S, Odaci E, et al. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 2003; 47 (2): 149-56
35. Fadillioglu E, Erdogan H. Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res 2003; 47 (4): 317-22
36. Reichenberger F, Tamm M. N-acetylcysteine in the therapy of chronic bronchitis. Pneumologie 2002; 56 (12): 793-7
37. Rogers DF. Mucoactive drugs for asthma and COPD: any place in therapy? Expert Opin Investig Drugs 2002; 11 (1): 15-35
38. Yen GC, Lai HH. Inhibition of reactive nitrogen species effects in vitro and in vivo by isoflavones and soy-based food extracts. J Agric Food Chem 2003; 51 (27): 7892-900
39. Bergamini S, Rota C, Canali R, et al. N-acetyleysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 2001; 5 (4): 349-60
40. Desideri G, Marinucci MC, Tomassoni G, et al. Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients. J Clin Endocrinol Metab 2002; 87 (6): 2940-5